Literature DB >> 9180123

Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure.

T P Chua1, P Ponikowski, D Harrington, S D Anker, K Webb-Peploe, A L Clark, P A Poole-Wilson, A J Coats.   

Abstract

OBJECTIVES: This study sought to investigate the clinical characteristics of patients with chronic heart failure and an increased ventilatory response to exercise and to examine the prognostic usefulness of this response.
BACKGROUND: The ventilatory response to exercise is increased in many patients with chronic heart failure and may be characterized by the regression slope relating minute ventilation to carbon dioxide output (VE-VCO2 slope) during exercise.
METHODS: One hundred seventy-three consecutive patients (155 men; mean [+/-SD] age 59.8 +/- 11.5 years; radionuclide left ventricular ejection fraction [LVEF] 28.4 +/- 14.6%) underwent cardiopulmonary exercise testing (peak oxygen consumption 18.5 +/- 7.3 ml/kg per min; VE-CO2 slope 34.8 +/- 10.6) over a 2-year period. Using 1.96 standard deviations above the mean VE-VCO2 slope of 68 healthy age-matched subjects (mean slope 26.3 +/- 4.1), we defined a high ventilatory response to exercise as a slope >34.
RESULTS: Eighty-three patients (48%) had an increased VE-VCO2 slope (mean 43.1 +/- 8.9). There was a difference in age (62.2 vs. 57.3 years, p = 0.005), New York Heart Association functional class (2.9 vs. 2.1, p < 0.001), LVEF (24.7 vs. 31.9%, p = 0.0016), peak oxygen consumption (14.9 vs. 21.7 ml/kg per min, p < 0.0001) and radiographic cardiothoracic ratio (0.58 vs. 0.55, p = 0.002) between these patients and those with a normal slope. In the univariate Cox proportional hazards model, the E-VCO2 slope was an important prognostic factor (p < 0.0001). In the multivariate Cox analyses using several variables (age, peak oxygen consumption, VE-VCO2 slope and LVEF), the VE-VCO2 slope gave additional prognostic information (p = 0.018) beyond peak oxygen consumption (p = 0.022). Kaplan-Meier survival curves at 18 months demonstrated a survival rate of 95% in patients with a normal VE-VCO2 slope compared with 69% in those with a high slope (p < 0.0001).
CONCLUSIONS: A high VE-VCO2 slope selects patients with more severe heart failure and is an independent prognostic marker. The VE-VCO2 slope may be used as a supplementary index in the assessment of patients with chronic heart failure.

Entities:  

Mesh:

Year:  1997        PMID: 9180123     DOI: 10.1016/s0735-1097(97)00078-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  80 in total

Review 1.  Exercise testing in the assessment of chronic congestive heart failure.

Authors:  John G Lainchbury; A Mark Richards
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

2.  Brain natriuretic peptide facilitates severity classification of stable chronic heart failure with left ventricular dysfunction.

Authors:  S Sakurai; H Adachi; A Hasegawa; H Hoshizaki; S Oshima; K Taniguchi; M Kurabayashi
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

3.  Submaximal exercise gas exchange is an important prognostic tool to predict adverse outcomes in heart failure.

Authors:  Paul R Woods; Kent R Bailey; Christina M Wood; Bruce D Johnson
Journal:  Eur J Heart Fail       Date:  2010-10-29       Impact factor: 15.534

Review 4.  Exercise testing with concurrent beta-blocker usage: is it useful? What do we learn?

Authors:  Eugene E Wolfel
Journal:  Curr Heart Fail Rep       Date:  2006-06

5.  Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs.

Authors:  Yukitaka Shizukuda; Kevin P Smith; Dorothy J Tripodi; Ross Arena; Yu-Ying Yau; Charles D Bolan; Myron A Waclawiw; Susan F Leitman; Douglas R Rosing
Journal:  Am J Phys Med Rehabil       Date:  2012-05       Impact factor: 2.159

6.  Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis.

Authors:  Adil Yunis; Gheorge Doros; Ivan Luptak; Lawreen H Connors; Flora Sam
Journal:  Am J Cardiol       Date:  2019-04-09       Impact factor: 2.778

Review 7.  Heart failure: What causes the symptoms of heart failure?

Authors:  A J Coats
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

Review 8.  Integrated Cardio-Respiratory Control: Insight in Diabetes.

Authors:  Luciano Bernardi; Lucio Bianchi
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 9.  Cardiopulmonary exercise testing and its application.

Authors:  Khaled Albouaini; Mohaned Egred; Albert Alahmar; David Justin Wright
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

10.  Serum cholinesterase is an important prognostic factor in chronic heart failure.

Authors:  Takamasa Sato; Hiroyuki Yamauchi; Satoshi Suzuki; Akiomi Yoshihisa; Takayoshi Yamaki; Koichi Sugimoto; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-ichi Saitoh; Yasuchika Takeishi
Journal:  Heart Vessels       Date:  2014-01-25       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.